The expression of PLK-1 in cervical carcinoma: a possible target for enhancing chemosensitivity
<p>Abstract</p> <p>Background</p> <p>Polo-like kinase-1 (PLK-1) is reported to be upregulated in a variety of human tumors and is implicated in cell proliferation and survival. However, its importance in cervical carcinoma has not yet been fully elucidated.</p> &l...
Main Authors: | Li Hua-Bin, Zhang Hong-Xiu, Xia Jia-Hong, Yang Yuan-Xian, Liu Yu, Zhang Yuan, Yu Chun-Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-09-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Online Access: | http://www.jeccr.com/content/28/1/130 |
Similar Items
-
Combination of PI3K/Akt Pathway Inhibition and Plk1 Depletion Can Enhance Chemosensitivity to Gemcitabine in Pancreatic Carcinoma
by: Yonghuan Mao, et al.
Published: (2018-08-01) -
A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinomaResearch in context
by: Mengjiao Wu, et al.
Published: (2019-03-01) -
Enhanced Chemosensitivity by Targeting Nanog in Head and Neck Squamous Cell Carcinomas
by: Chuan-En Huang, et al.
Published: (2014-08-01) -
Targeting claudin‐4 enhances chemosensitivity of pancreatic ductal carcinomas
by: Takamitsu Sasaki, et al.
Published: (2019-11-01) -
Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255]
by: Mengjiao Wu, et al.
Published: (2021-01-01)